SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotransplant(BTRN)
BTRN 35.28+0.5%Nov 5 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Torben Noerup Nielsen who wrote (1197)1/5/2002 1:30:25 PM
From: Arthur Radley  Read Replies (1) of 1475
 
Torben,
They will probably sell all the shares that have been allocated. However, I don't expect that to happen anytime in the near future..(month). There is much information and events that will be delivered in the very near future.
1) Initiate MEDI-507 Phase I/II psoriatic arthritis trials
2) Initiate MEDI-507 Phase III psoriasis trials
3) MEDI-507 Phase II psoriasis data
4) Initiate U.S. Phase III TCELL-HDM studies
5) Initiate Phase I/II Allomune lymphoma studies

All of these events are schedule in the first half of 2002. The biggest event IMO will be the Phase II psoriasis data and the announcement of Phase III trials. IMO this will get us into the $15.00 range and will be the time for selling the shares. Management would be foolish(IMO) to issue them now...with all this news coming within 6 months.

And to the list mentioned above I should add that with the 4th Q release we will get the first actual product revenue sales for the company. That being the European sales for BCELL-HDM and TCELL-HDM. One analyst has projected $700,000 for BCell and $300,000 for TCell and IMO this will bode well for revenue numbers for such a limited time on the market. $1,000,000 in product revenue is just the tip of the iceberg...(:>)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News